Yuyu Pharma Inc (000225) — Cash Flow-to-Debt Ratio
Yuyu Pharma Inc (000225) has a Cash Flow-to-Debt Ratio of 0.05x as of March 2026, meaning its operating cash flow of ₩2.95 Billion could theoretically repay 0% of its total liabilities (₩64.72 Billion) in one year. Explore Yuyu Pharma Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Yuyu Pharma Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Yuyu Pharma Inc across 12 annual periods. Also explore 000225 total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Yuyu Pharma Inc (2014–2025)
Year-by-year debt coverage analysis for Yuyu Pharma Inc. For market capitalisation and broader financial context, see 000225 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.24x | ₩15.88 Billion | ₩66.68 Billion | ▼ -30.7% |
| 2024 | 0.34x | ₩24.95 Billion | ₩72.62 Billion | ▲ +6255.6% |
| 2023 | 0.01x | ₩420.86 Million | ₩77.86 Billion | ▲ +106.2% |
| 2022 | -0.09x | ₩-6.23 Billion | ₩71.83 Billion | ▼ -223.7% |
| 2021 | 0.07x | ₩4.51 Billion | ₩64.30 Billion | ▲ +199.5% |
| 2020 | -0.07x | ₩-2.67 Billion | ₩37.86 Billion | ▼ -125.2% |
| 2019 | 0.28x | ₩13.19 Billion | ₩47.17 Billion | ▲ +121.2% |
| 2018 | 0.13x | ₩6.11 Billion | ₩48.35 Billion | ▲ +770.2% |
| 2017 | 0.01x | ₩561.35 Million | ₩38.66 Billion | ▼ -95.1% |
| 2016 | 0.30x | ₩9.82 Billion | ₩33.01 Billion | ▲ +177.9% |
| 2015 | -0.38x | ₩-11.68 Billion | ₩30.60 Billion | ▼ -937.8% |
| 2014 | 0.05x | ₩1.36 Billion | ₩29.91 Billion | — |